Mivebresib, CAS [[1445993-26-9]]

Produktübersicht

• Artikelname: Mivebresib, CAS [[1445993-26-9]]
• Artikelnummer: TGM-T3712
• Hersteller Artikelnummer: T3712
• Alternativnummer: TGM-T3712-1MLX10MM(INDMSO),TGM-T3712-1MG,TGM-T3712-2MG,TGM-T3712-5MG,TGM-T3712-10MG,TGM-T3712-25MG,TGM-T3712-50MG,TGM-T3712-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: ABBV-075

Produktbeschreibung

Mivebresib (ABBV-075), also known as ABBV-075, is a potent BET inhibitor (bromodomain (BRD)-containing protein) with potential antineoplastic activity. Upon administration, the bromodomain inhibitor ABBV-075 binds to the acetyl-lysine binding site in the BRD of certain BRD-containing protein(s), thereby preventing the interaction between those proteins and acetylated histones. This disrupts chromatin remodeling, prevents the expression of certain growth-promoting genes, and leads to an inhibition of cell growth in susceptible tumors. Also a potent inhibitor of MYC and the TMPRSS2-ETS fusion proteins.

Produkteigenschaften

• Molekulargewicht: 459.47
• Reinheit: 97.17%
• CAS Nummer: [1445993-26-9]
• Formel: C22H19F2N3O4S
• Target-Kategorie: Epigenetic Reader Domain|||Apoptosis

Bilder

T3712